Company: VRCA
Filing Date: 2025-04-30
Form Type: DEFR14A
Source: 0001193125-25-105562
Chunk: 8

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-04-30
Form: DEFR14A
Chunk 8
---
 will be counted by the inspection of elections appointed for the Annual Meeting.

| Proposal 
 Number   |     | Proposal Description                                                                                                                   |     | Vote Required for Approval                                                                                                                     |     | Effect of      
 Abstentions    |     | Effect of                          
 Broker Non- Votes                  |
| 1.       |     | Election of Directors                                                                                                                  |     | Nominees receiving the most “For” votes; withheld votes will have no effect.                                                                   |     | Not applicable |     | No effect                          |
| 2.       |     | Non-binding advisory approval of the compensation of our named executive officers(1)                                                   |     | “For” votes from the holders of a majority of shares present at the Annual Meeting or represented by proxy and entitled to vote on the matter. |     | Against        |     | No effect                          |
| 3.       |     | Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2024 |     | “For” votes from holders of a majority of shares present at the Annual Meeting or represented by proxy and entitled to vote on the matter.     |     | Against        |     | Brokers have discretion to vote(2) |
| 4.       |     | Reverse Stock Split                                                                                                                    |     | “For” votes from the holders of a majority of the total votes cast on the proposal.                                                            |     | No effect      |     | Brokers have discretion to vote(2) |

| (1) | As this is an advisory vote, the result will not be binding on our Board. However, our Board values our stockholders’ opinions, and our Board and the Compensation Committee will take into account the outcome of the advisory vote when considering future named executive officer compensation decisions. |

5

| (2) | This proposal is considered a “routine” matter under NYSE rules. Accordingly, if you hold your shares in street name and do not provide voting instructions to your broker, bank or other agent that holds your shares, your broker, bank or other agent has discretionary authority under NYSE rules to vote your shares on this proposal. We do not expect there to be broker-non votes on this matter. |

What is the quorum requirement? A quorum of stockholders is necessary to hold a valid meeting. A quorum is present if stockholders holding at least a majority of the outstanding shares entitled to vote are present at the Annual Meeting in person or represented by